US Patent Issued to NantCell, NantBio on Dec. 2 for "Rapid verification of virus particle production for a personalized vaccine" (California Inventors)

ALEXANDRIA, Va., Dec. 2 -- United States Patent no. 12,487,241, issued on Dec. 2, was assigned to NantCell Inc. (Culver City, Calif.) and NantBio Inc. (Culver City, Calif.).

"Rapid verification of virus particle production for a personalized vaccine" was invented by Adrian E. Rice (Culver City, Calif.), Kayvan Niazi (Culver City, Calif.) and Frank R. Jones (Culver City, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Methods for rapidly confirming production of infectious viral vectors, for use in clinical grade personalized neo-antigen vaccines for subjects in need thereof, are provided."

The patent was filed on Dec. 16, 2022, under Application No. 18/067,508.

*For further information, including ima...